Marc Le Bozec, Chief Executive Officer at OSE Immunotherapeutics commented: “This strategy positions OSE for success by concentrating resources where they can create the most value for all our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback